rs17860422

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001080125.2(CASP8):​c.516C>T​(p.Ser172Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00372 in 1,608,458 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 26 hom. )

Consequence

CASP8
NM_001080125.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.689

Publications

4 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-201271549-C-T is Benign according to our data. Variant chr2-201271549-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 333498.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.689 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0031 (473/152356) while in subpopulation NFE AF = 0.00472 (321/68040). AF 95% confidence interval is 0.00429. There are 1 homozygotes in GnomAd4. There are 239 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 26 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001080125.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
NM_001372051.1
MANE Select
c.339C>Tp.Ser113Ser
synonymous
Exon 3 of 9NP_001358980.1
CASP8
NM_001080125.2
c.516C>Tp.Ser172Ser
synonymous
Exon 3 of 9NP_001073594.1
CASP8
NM_001400642.1
c.516C>Tp.Ser172Ser
synonymous
Exon 3 of 8NP_001387571.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
ENST00000673742.1
MANE Select
c.339C>Tp.Ser113Ser
synonymous
Exon 3 of 9ENSP00000501268.1
CASP8
ENST00000358485.8
TSL:1
c.516C>Tp.Ser172Ser
synonymous
Exon 3 of 9ENSP00000351273.4
CASP8
ENST00000264275.9
TSL:1
c.435C>Tp.Ser145Ser
synonymous
Exon 5 of 10ENSP00000264275.5

Frequencies

GnomAD3 genomes
AF:
0.00311
AC:
474
AN:
152238
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00439
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00473
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00347
AC:
872
AN:
251394
AF XY:
0.00356
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00367
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00263
Gnomad NFE exome
AF:
0.00475
Gnomad OTH exome
AF:
0.00424
GnomAD4 exome
AF:
0.00379
AC:
5514
AN:
1456102
Hom.:
26
Cov.:
28
AF XY:
0.00380
AC XY:
2753
AN XY:
724764
show subpopulations
African (AFR)
AF:
0.000779
AC:
26
AN:
33364
American (AMR)
AF:
0.00387
AC:
173
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00180
AC:
47
AN:
26084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.00252
AC:
217
AN:
86138
European-Finnish (FIN)
AF:
0.00247
AC:
132
AN:
53418
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5760
European-Non Finnish (NFE)
AF:
0.00425
AC:
4709
AN:
1106724
Other (OTH)
AF:
0.00330
AC:
199
AN:
60226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
269
538
807
1076
1345
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00310
AC:
473
AN:
152356
Hom.:
1
Cov.:
32
AF XY:
0.00321
AC XY:
239
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000601
AC:
25
AN:
41590
American (AMR)
AF:
0.00438
AC:
67
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4822
European-Finnish (FIN)
AF:
0.00301
AC:
32
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00472
AC:
321
AN:
68040
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00382
Hom.:
1
Bravo
AF:
0.00325
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00578
EpiControl
AF:
0.00599

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Autoimmune lymphoproliferative syndrome type 2B (2)
-
-
2
not provided (2)
-
-
1
Lung cancer;C0346153:Familial cancer of breast;C1846545:Autoimmune lymphoproliferative syndrome type 2B;C2239176:Hepatocellular carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.5
DANN
Benign
0.44
PhyloP100
-0.69
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17860422; hg19: chr2-202136272; API